Calidi Biotherapeutics, Inc. (CLDI): Weighted Average Diluted Shares
Annual figures by period end, from SEC filings.
Stock splits: 1-for-12, first reflected in a filing dated 2025-08-08; 1-for-16, first reflected in a filing dated 2026-08-13. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.
Figures left out. The filed Weighted Average Diluted Shares for the year ended 2025-12-31 is not shown: share count out of scale with net income per share. That usually means the filing tagged the figure in the wrong unit.
8.01M
Year ended 2024-12-31
2022-12-31Weighted Average Diluted Shares (shares)2024-12-31